Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3
Open Access
- 10 July 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (7) , 14321-14332
Abstract
Thrombospondin-1 (TSP-1), a matricellular protein widely acclaimed to be involved in the inhibition of angiogenesis and tumorigenesis, is synthesized and secreted by many cell types, including osteoblast and cancer cells. TSP-1 is highly upregulated during early stage of osteogenesis, whereas it inhibits terminal osteoblast differentiation. Expression of TSP-1 is downregulated in cancer cells, and its ectopic expression has been shown to restrain tumor growth. Transcriptional regulation of TSP-1 in osteogenesis and cancer is poorly understood; this prompted us to study its regulation by the two key regulators of the aforementioned processes: Runx2 and Runx3. Through a PCR-based cDNA subtraction technique, we identified and cloned a cDNA fragment for mouse TSP-1, whose expression was dramatically upregulated in response to Runx2 expression in mesenchymal stem cells. Moreover, TSP-1 expression was considerably reduced in the lung of Runx2 knockout mouse. On the other hand, TSP-1 gene expression drastically increased at both the transcriptional and translational levels in response to Runx3 expression in B16-F10 melanoma cells. In line with this, Runx2 and Runx3 bound to the TSP-1 promoter and stimulated its activity. Hence, these results provide first line of evidence that TSP-1 is a transcriptional target gene of Runx2 and Runx3.Keywords
This publication has 44 references indexed in Scilit:
- RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell CarcinomaPLOS ONE, 2013
- Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activationBiochemical and Biophysical Research Communications, 2012
- Thrombospondins in physiology and disease: New tricks for old dogsMatrix Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of ActionPharmaceuticals, 2010
- Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous MelanomaClinical Cancer Research, 2009
- Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 CellsCancer Research, 2008
- Thrombospondin-1 Is an Adipokine Associated With Obesity, Adipose Inflammation, and Insulin ResistanceDiabetes, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Thrombospondin-based antiangiogenic therapyMicrovascular Research, 2007